Stem cell banking partnership targets future of longevity
AcCELLerated Biologics and Forever Labs team up to make regenerative medicine more accessible and personalized. Retirement accounts are built on a simple idea of putting something valuable away today so you’ll. . .
AcCELLerated Biologics and Forever Labs team up to make regenerative medicine more accessible and personalized. Retirement accounts are built on a simple idea of putting something valuable away today so you’ll have it when you need it decades from now. What if we started thinking about our biology the same way?A new partnership betweenAcCELLerated BiologicsandForever Labshas been formed, two companies betting that one of the next frontiers in longevity will be about preserving some of our body’s regenerative capacity before it begins to decline [1]. In an era increasingly shaped by biohacking, personalized health and the growing longevity economy, the idea is intuitive. Rather than waiting until age-related issues emerge, individuals can collect and store their own adult stem cells while they are younger and potentially more robust, creating a personal biological reserve that may one day support future therapies. Think of it as putting a snapshot of your younger biology into storage. The concept remains ambitious, and many future applications are still evolving. Yet the growing interest in stem cell banking reflects how healthcare is moving away from a model centered on disease management and toward one focused on maintaining healthspan. AcCELLerated Biologics, a regenerative medicine company founded by industry veteran Steve Whyte, has entered into a strategic partnership with Forever Labs, a company specializing in adult stem cell collection, cryopreservation and long-term storage. The collaboration brings together two sides of the regenerative medicine equation. AcCELLerated Biologics has built its business around providing physicians with biologic therapies derived from a patient’s own tissues, while Forever Labs focuses on collecting and preserving stem cells for potential future use. For patients, the goal is a more seamless pathway into regenerative medicine. For clinics, it creates access to a broader set of tools that can support increasingly personalized treatment strategies. Steve Whyte, founder and CEO of AcCELLerated Biologics, expressed his excitement about partnering with Forever Labs to deliver advanced stem cell storage capabilities and infrastructure directly to their network of clinicians and patients. He emphasized that AcCELLerated Biologics had always been committed to providing top-quality autologous biologics and supporting physicians with reliable tools for regenerative medicine. “This collaboration enhances our offerings by incorporating secure, long-term stem cell cryopreservation, empowering patients to bank their own cells today for personalized therapies. Together, we are accelerating the future of regenerative care,” he added. Stem cells are frequently discussed as breakthrough science, yet the underlying concept is straightforward. Our bodies contain stem cells that help repair and replenish tissues throughout life. As we age, however, both the number and performance of these cells can decline. The logic behind stem cell banking is similar to saving high-quality seeds from a healthy harvest before environmental conditions change. The hope is that by preserving cells earlier in life, patients may have access to younger biological material if future treatments require it. Forever Labs collects adult stem cells through a minimally invasive outpatient procedure and stores them in accredited US facilities using cryopreservation, a process that keeps cells viable at extremely low temperatures for long periods of time. According to Kevin Virgil, CEO of Forever Labs, the company’s partnership with AcCELLerated Biologics marks a major advancement in enhancing the accessibility and clinical integration of fully personalized regenerative therapies across the US. He noted that their laboratories located in Michigan and Florida allow individuals to safeguard their biological potential at its peak through a process that includes rigorous testing, cryopreservation and secure, long-term storage. “We are particularly excited about the opportunities in Florida, where recent state guidelines provide a supportive framework for therapeutic applications using cell culture and expansion. This partnership helps board-certified physicians offer compliant, forward-looking solutions that align with evolving regulations while prioritizing patient safety and innovation,” he added. The announcement highlights the growing role Florida is playing in regenerative medicine. Recent state legislation has established clearer standards governing how patients’ own stem cells can be collected, stored, manufactured and used [2]. Supporters argue that this regulatory clarity creates a framework for innovation while maintaining quality and safety requirements. For companies operating in regenerative medicine, certainty matters. Building infrastructure around stem cell banking requires long-term investment, and clearer rules make it easier for businesses, clinicians and patients to participate with greater confidence. As a result, Florida is increasingly positioning itself as a destination for companies looking to develop next-generation longevity and regenerative health solutions. Now, the bigger story is that healthspan becomes an asset class. For decades, healthcare has largely functioned as a repair service. Something breaks, symptoms appear and treatment follows. Longevity science is beginning to challenge that sequence. Whether through biomarker testing, preventive diagnostics, precision nutrition, or regenerative medicine, the industry’s attention is increasingly focused on preserving function rather than restoring it after loss has occurred. Stem cell banking sits squarely within that emerging mindset. It treats biological resilience as something worth protecting in advance. That does not mean stem cells are a guaranteed solution to future age-related disease. The science continues to develop, and many applications remain under investigation. However, the growing investment in collection, storage and regenerative medicine infrastructure suggests that industry leaders believe personalized biologics will play a larger role in future healthcare. Dr Tad DeWald, founder and Chief Medical Officer ofFlorida Regen, said that Florida is quickly establishing itself as a leading hub for regenerative medicine, which he attributed to an environment that emphasizes therapeutic innovation and patient access. He expressed pride in Florida Regen’s involvement in the strategic partnership between AcCELLerated Biologics and Forever Labs, noting that the collaboration marks a major advancement for providers working at the cutting edge of regenerative care. “By uniting the full spectrum of autologous biologics – PRP, bone marrow, adipose and exosomes – with stem cell banking and the capacity to culture expand a patient’s own cells, we are ensuring that both providers and patients have every tool available to pursue the most personalized, advanced treatment possible,” DeWald said. The first phase of the partnership will focus on physician education, training initiatives and integrated service offerings for clinics in Florida and beyond. Viewed through a longevity lens, the announcement feels like a signpost. For years, the longevity conversation revolved around extending lifespan. Today, the discussion is becoming more practical: how do we preserve health, mobility, resilience and independence for as long as possible? The answer may come from building systems that allow people to safeguard valuable biological resources before they are needed. If retirement planning is about protecting your future financial self, stem cell banking raises a provocative new question: could preserving your younger cells become a form of planning for your future biological self? As longevity moves further into the mainstream, that idea may sound like the next chapter of preventive healthcare. [1]https://www. prnewswire. com/news-releases/accellerated-biologics-announces-strategic-partnership-with-forever-labs-to-advance-stem-cell-storage-and-regenerative-medicine-solutions-302795562. html[2]https://fidjlaw. com/floridas-new-stem-cell-laws-unburdened-by-what-has-been/